Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gunther Marsche

Showing results (41-50 of 135) with videos related to

Pageof 14
Sort By:
Journal of Leukocyte Biology|March 6, 2020
Frontline Science: Superior mouse eosinophil depletion in vivo targeting transgenic Siglec-8 instead of endogenous Siglec-F: Mechanisms and pitfallsEva Knuplez, Rebecca Krier-Burris, Yun Cao, et al.
Scientific Reports|September 15, 2020
Prolonged bedrest reduces plasma high-density lipoprotein levels linked to markedly suppressed cholesterol efflux capacityAthina Trakaki, Hubert Scharnagl, Markus Trieb, et al.
Journal of Clinical Lipidology|November 30, 2020
Impaired cholesterol efflux capacity in patients with Helicobacter pylori infection and its relation with inflammationSoudabeh Fallah, Gunther Marsche, Maryam Mohamadinarab, et al.
Antioxidants (Basel, Switzerland)|October 27, 2022
Low HDL Cholesterol Efflux Capacity Indicates a Fatal Course of COVID-19Julia T Stadler, Harald Mangge, Alankrita Rani, et al.
British Journal of Pharmacology|January 15, 2021
The anti-parasitic drug miltefosine suppresses activation of human eosinophils and ameliorates allergic inflammation in miceEva Knuplez, Melanie Kienzl, Athina Trakaki, et al.
Free Radical Biology & Medicine|June 9, 2019
Human myeloperoxidase (hMPO) is expressed in neurons in the substantia nigra in Parkinson's disease and in the hMPO-α-synuclein-A53T mouse model, correlating with increased nitration and aggregation of α-synuclein and exacerbation of motor impairmentRichard A Maki, Michael Holzer, Khatereh Motamedchaboki, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 30, 2004
2-chlorohexadecanal derived from hypochlorite-modified high-density lipoprotein-associated plasmalogen is a natural inhibitor of endothelial nitric oxide biosynthesisGunther Marsche, Regine Heller, Günter Fauler, et al.
Frontiers in Cell and Developmental Biology|January 24, 2022
Impact of Sepsis on High-Density Lipoprotein MetabolismAlexander C Reisinger, Max Schuller, Harald Sourij, et al.
The Journal of Clinical Endocrinology and Metabolism|September 23, 2017
Adiponectin Predicts High-Density Lipoprotein Cholesterol Efflux Capacity in Adults Irrespective of Body Mass Index and Fat DistributionGunther Marsche, Sieglinde Zelzer, Andreas Meinitzer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 13, 2010
The prostaglandin E2 receptor EP4 is expressed by human platelets and potently inhibits platelet aggregation and thrombus formationSonia Philipose, Viktoria Konya, Ivana Sreckovic, et al.
Pageof 14

Showing results (41-50 of 135) with videos related to

Sort By:
Pageof 14
Journal of Leukocyte Biology|March 6, 2020
Frontline Science: Superior mouse eosinophil depletion in vivo targeting transgenic Siglec-8 instead of endogenous Siglec-F: Mechanisms and pitfallsEva Knuplez, Rebecca Krier-Burris, Yun Cao, et al.
Scientific Reports|September 15, 2020
Prolonged bedrest reduces plasma high-density lipoprotein levels linked to markedly suppressed cholesterol efflux capacityAthina Trakaki, Hubert Scharnagl, Markus Trieb, et al.
Journal of Clinical Lipidology|November 30, 2020
Impaired cholesterol efflux capacity in patients with Helicobacter pylori infection and its relation with inflammationSoudabeh Fallah, Gunther Marsche, Maryam Mohamadinarab, et al.
Antioxidants (Basel, Switzerland)|October 27, 2022
Low HDL Cholesterol Efflux Capacity Indicates a Fatal Course of COVID-19Julia T Stadler, Harald Mangge, Alankrita Rani, et al.
British Journal of Pharmacology|January 15, 2021
The anti-parasitic drug miltefosine suppresses activation of human eosinophils and ameliorates allergic inflammation in miceEva Knuplez, Melanie Kienzl, Athina Trakaki, et al.
Free Radical Biology & Medicine|June 9, 2019
Human myeloperoxidase (hMPO) is expressed in neurons in the substantia nigra in Parkinson's disease and in the hMPO-α-synuclein-A53T mouse model, correlating with increased nitration and aggregation of α-synuclein and exacerbation of motor impairmentRichard A Maki, Michael Holzer, Khatereh Motamedchaboki, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 30, 2004
2-chlorohexadecanal derived from hypochlorite-modified high-density lipoprotein-associated plasmalogen is a natural inhibitor of endothelial nitric oxide biosynthesisGunther Marsche, Regine Heller, Günter Fauler, et al.
Frontiers in Cell and Developmental Biology|January 24, 2022
Impact of Sepsis on High-Density Lipoprotein MetabolismAlexander C Reisinger, Max Schuller, Harald Sourij, et al.
The Journal of Clinical Endocrinology and Metabolism|September 23, 2017
Adiponectin Predicts High-Density Lipoprotein Cholesterol Efflux Capacity in Adults Irrespective of Body Mass Index and Fat DistributionGunther Marsche, Sieglinde Zelzer, Andreas Meinitzer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 13, 2010
The prostaglandin E2 receptor EP4 is expressed by human platelets and potently inhibits platelet aggregation and thrombus formationSonia Philipose, Viktoria Konya, Ivana Sreckovic, et al.
Pageof 14